aTyr Pharma, Inc. (ATYR) support and resistance · rev $190.0K
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
This page maps aTyr Pharma, Inc. (ATYR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ATYR revenue for 2025-09-30 was $190.0K. Net income was -$25.7M. ATYR currently screens at market cap $471.7M.
ATYR currently screens at market cap $471.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ATYR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ATYR quote page for the session range and the stock page for the full model.
Not investment advice.